Defence Therapeutics Inc. (CSE:DTC)
Canada · Delayed Price · Currency is CAD 0.4000
+0.0200 (5.26%)
Oct 9, 2026, 1:37 PM EST
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of CAD 30.32 million as of October 9, 2026. It is the 36,737th most valuable company in the world and the 1,168th biggest in Canada. Its market cap has decreased by 31.61% in one year.
Market Cap
30.32M
Enterprise Value
28.93M
Revenue
n/a
Global Rank
Country Rank
#1,168 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 89.08M to 30.32M, a decrease of -65.97%. That is a compound annual growth rate of -18.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 30.32M | -26.61% |
| Dec 31, 2025 | 41.31M | 31.21% |
| Dec 31, 2024 | 31.48M | -69.62% |
| Dec 29, 2023 | 103.61M | 5.29% |
| Dec 30, 2022 | 98.41M | -49.44% |
| Dec 31, 2021 | 194.63M | 118.48% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 42.46M |
| Medicenna Therapeutics | 41.07M |
| Sona Nanotech | 38.68M |
| Thiogenesis Therapeutics | 34.29M |
| Telescope Innovations | 33.54M |
| The More Life Company | 31.99M |
| Resverlogix | 29.26M |
| Pharmala Biotech Holdings | 23.03M |